Beam Therapeutics Inc : Bernstein Raises to Outperform From Market Perform; Raises Target Price to $37 From $35
Beam Therapeutics Inc : Bernstein将评级从市场表现上调至优于市场;目标价从35美元上调至37美元
Beam Therapeutics Inc : Bernstein Raises to Outperform From Market Perform; Raises Target Price to $37 From $35
Beam Therapeutics Inc : Bernstein将评级从市场表现上调至优于市场;目标价从35美元上调至37美元
译文内容由第三方软件翻译。